These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23236065)
1. Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature. Luongo C; Winter CC; Collins PL; Buchholz UJ J Virol; 2013 Feb; 87(4):1985-96. PubMed ID: 23236065 [TBL] [Abstract][Full Text] [Related]
2. Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children. Karron RA; Luongo C; Mateo JS; Wanionek K; Collins PL; Buchholz UJ J Infect Dis; 2020 Jun; 222(1):82-91. PubMed ID: 31605113 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children. Cunningham CK; Karron RA; Muresan P; Kelly MS; McFarland EJ; Perlowski C; Libous J; Oliva J; Jean-Philippe P; Moye J; Schappell E; Barr E; Rexroad V; Johnston B; Chadwick EG; Cielo M; Paul M; Deville JG; Aziz M; Yang L; Luongo C; Collins PL; Buchholz UJ; J Infect Dis; 2022 Dec; 226(12):2069-2078. PubMed ID: 35732186 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein. Alamares-Sapuay J; Kishko M; Lai C; Parrington M; Delagrave S; Herbert R; Castens A; Swerczek J; Luongo C; Yang L; Collins PL; Buchholz UJ; Zhang L PLoS One; 2024; 19(4):e0301773. PubMed ID: 38593167 [TBL] [Abstract][Full Text] [Related]
5. Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics. Luongo C; Winter CC; Collins PL; Buchholz UJ J Virol; 2012 Oct; 86(19):10792-804. PubMed ID: 22837193 [TBL] [Abstract][Full Text] [Related]
6. Codon stabilization analysis of the "248" temperature sensitive mutation for increased phenotypic stability of respiratory syncytial virus vaccine candidates. Luongo C; Yang L; Winter CC; Spann KM; Murphy BR; Collins PL; Buchholz UJ Vaccine; 2009 Sep; 27(41):5667-76. PubMed ID: 19646406 [TBL] [Abstract][Full Text] [Related]
7. Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein. Xue M; Wang R; Harder O; Chen P; Lu M; Cai H; Li A; Liang X; Jennings R; La Perle K; Niewiesk S; Peeples ME; Li J J Virol; 2020 Nov; 94(24):. PubMed ID: 32999025 [TBL] [Abstract][Full Text] [Related]
8. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children. McFarland EJ; Karron RA; Muresan P; Cunningham CK; Perlowski C; Libous J; Oliva J; Jean-Philippe P; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Cielo M; Wiznia A; Deville JG; Yang L; Luongo C; Collins PL; Buchholz UJ J Infect Dis; 2020 Jun; 221(12):2050-2059. PubMed ID: 32006006 [TBL] [Abstract][Full Text] [Related]
9. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. Whitehead SS; Firestone CY; Karron RA; Crowe JE; Elkins WR; Collins PL; Murphy BR J Virol; 1999 Feb; 73(2):871-7. PubMed ID: 9882287 [TBL] [Abstract][Full Text] [Related]
10. A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats. Rostad CA; Stobart CC; Gilbert BE; Pickles RJ; Hotard AL; Meng J; Blanco JCG; Moin SM; Graham BS; Piedra PA; Moore ML J Virol; 2016 Aug; 90(16):7508-7518. PubMed ID: 27279612 [TBL] [Abstract][Full Text] [Related]
11. Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters. Levy M; Chen JW; Kaiser JA; Park HS; Liu X; Yang L; Santos C; Buchholz UJ; Le Nouën C PLoS Pathog; 2024 May; 20(5):e1012198. PubMed ID: 38739647 [TBL] [Abstract][Full Text] [Related]
12. A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque. Jenkins T; Wang R; Harder O; Xue M; Chen P; Corry J; Walker C; Teng M; Mejias A; Ramilo O; Niewiesk S; Li J; Peeples ME J Virol; 2021 Jan; 95(3):. PubMed ID: 33177201 [TBL] [Abstract][Full Text] [Related]
13. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine. Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633 [TBL] [Abstract][Full Text] [Related]
14. Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children. McFarland EJ; Karron RA; Muresan P; Cunningham CK; Libous J; Perlowski C; Thumar B; Gnanashanmugam D; Moye J; Schappell E; Barr E; Rexroad V; Fearn L; Spector SA; Aziz M; Cielo M; Beneri C; Wiznia A; Luongo C; Collins P; Buchholz UJ J Infect Dis; 2020 Feb; 221(4):534-543. PubMed ID: 31758177 [TBL] [Abstract][Full Text] [Related]
15. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques. Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656 [TBL] [Abstract][Full Text] [Related]
16. Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children. Buchholz UJ; Cunningham CK; Muresan P; Gnanashanmugam D; Sato P; Siberry GK; Rexroad V; Valentine M; Perlowski C; Schappell E; Thumar B; Luongo C; Barr E; Aziz M; Yogev R; Spector SA; Collins PL; McFarland EJ; Karron RA; J Infect Dis; 2018 Apr; 217(9):1338-1346. PubMed ID: 29509929 [TBL] [Abstract][Full Text] [Related]
18. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates. Whitehead SS; Hill MG; Firestone CY; St Claire M; Elkins WR; Murphy BR; Collins PL J Virol; 1999 Dec; 73(12):9773-80. PubMed ID: 10559287 [TBL] [Abstract][Full Text] [Related]
19. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. Whitehead SS; Bukreyev A; Teng MN; Firestone CY; St Claire M; Elkins WR; Collins PL; Murphy BR J Virol; 1999 Apr; 73(4):3438-42. PubMed ID: 10074199 [TBL] [Abstract][Full Text] [Related]
20. A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation. Stobart CC; Rostad CA; Ke Z; Dillard RS; Hampton CM; Strauss JD; Yi H; Hotard AL; Meng J; Pickles RJ; Sakamoto K; Lee S; Currier MG; Moin SM; Graham BS; Boukhvalova MS; Gilbert BE; Blanco JC; Piedra PA; Wright ER; Moore ML Nat Commun; 2016 Dec; 7():13916. PubMed ID: 28000669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]